Tobacco Smoking and Atherosclerosis: Overview

  • John N. Diana
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 273)

Abstract

Epidemiological studies from a variety of countries throughout the world have clearly established a relationship between smoking cigarettes and the development and/or progression of the atherosclerotic process (1). Although the epidemiologic evidence which correlates smoking and atherosclerosis is extensive, and thereby convincing, from a rigorous scientific point of view there are confounding variables in such studies which need further clarification. These confounding variables are life-style factors which predispose the individual to atherosclerotic disease in general (and coronary heart disease in particular), and are typified by sedentary living habits; obesity and/or unrestrained weight gain; a dietary intake which contains an excessive number of calories, fat, saturated fat, cholesterol, and salt; personal stress that is not modified; as well as cigarette smoking. It is not clear just how all of these risk factors interrelate among or between each other as variables in the pathogenesis of atherosclerosis. Analytical models which can unambiguously discriminate between such risk factors for a weighting of their contribution to the overall atherosclerotic process have yet to be developed.

Keywords

Cholesterol Obesity Cadmium Lipase Nicotine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    U.S. Office on Smoking and Health, “ The Health Consequences of Smoking: Cardiovascular Disease; a Report of the Surgeon General.” Washington, D.C., U.S. Government Printing Office, pp. 179–203, 1989.Google Scholar
  2. 2.
    Berg, Kare. Impact of medical genetics on research and practices in the area of cardiovascular disease. Clinical Genetics, 36: 299–312, 1989.PubMedGoogle Scholar
  3. 3.
    Ross, R. and A. Glomset. The pathogenesis of atherosclerosis. New Eng. J. Med. 295: 369–432, 1976.PubMedCrossRefGoogle Scholar
  4. 4.
    Haust, M.D. Injury and repair in the pathogenesis of atherosclerotic lesions. In: Atherosclerosis, (R.J. Jones, Ed.) Springer-Verlag, New York, pp. 12–20, 1970.Google Scholar
  5. 5.
    Brown, M.S. and J.L. Goldstein. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Proc. Nat. Acad. Sci. USA 70: 1753–1756, 1983.Google Scholar
  6. 6.
    Carotid Artery Plaques: Pathogenesis, Development, Evaluation, Treatment (M. Hennerici, G. Sitzer, H-D Weger, Eds). Bertelsmann Foundation, S. Karger, Publishing Co., New York, N.Y. Basel, 1988.Google Scholar
  7. 7.
    Chemistry and Analysis of Tobacco Smoke. In: IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Tobacco Smoking. International Agency for Research on Cancer, Publisher, Vol. 38: 83–126, 1986.Google Scholar
  8. 8.
    Brischetto, C.S., W.B. Connor, S.L. Connor, and J.D. Matarazzo. Plasma lipid and lipoprotein profiles of cigarette smokers from randomly selected families: enhancement of hyperlipidemia and depression of high density lipoprotein. Am. J. Cardiol. 62: 675–681, 1983.CrossRefGoogle Scholar
  9. 9.
    Barrett, T.B. and E.P. Benditt. Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall. Proc. Natl. Acad. Sci. 85: 2810–2814, 1988.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1990

Authors and Affiliations

  • John N. Diana
    • 1
  1. 1.Tobacco and Health Research InstituteUniversity of KentuckyLexingtonUSA

Personalised recommendations